Alternatives to SpotitEarly

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Next-generation molecular diagnostics for immediate and accurate pathogen detection anywhere.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.